MediPharm Labs Corp. (TSX:LABS)

Market Cap	29.90M -5.2%
Revenue (ttm)	41.46M -6.7%
Net Income	-4.97M
EPS	-0.01
Shares Out	427.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,831
Open	0.0650
Previous Close	0.0600
Day's Range	0.0600 - 0.0700
52-Week Range	0.0600 - 0.1000
Beta	0.84
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis p...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 127
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2025, MediPharm Labs's revenue was 45.12 million, an increase of 7.54% compared to the previous year's 41.96 million. Losses were -8.27 million, -22.69% less than in 2024.

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error